Also trades as: INDIAGLYCO.NS (NSE) · $vol 2M
INDIAGLYCO.BO BSE
India Glycols Limited
1W: -3.3%
1M: +29.9%
3M: -72.2%
YTD: -69.9%
1Y: -62.7%
3Y: -4.2%
5Y: -11.7%
₹306.80 ($3.19)
+8.20 (+2.75%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$6.5B
+79.8% ▲
5Y CAGR: +36.5%
Capital Expenditures
$8.2B
-8.3% ▼
5Y CAGR: +40.8%
Free Cash Flow
-$1.7B
+56.7% ▲
Dividends Paid
$753M
-206.3% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$276M
-37.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $3.5B | $1.5B | $2.1B | $2.3B | $2.9B |
| Depreciation & Amort. | $803M | $940M | $1.0B | $1.2B | $1.6B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$1.2B | $931M | $343M | -$1.1B | $1.4B |
| Other Non-Cash Items | -$1.9B | -$150M | $968M | $1.3B | $585M |
| Operating Cash Flow | $1.2B | $3.3B | $4.4B | $3.6B | $6.5B |
| — Investing Activities — | |||||
| Capital Expenditures | -$3.8B | -$4.4B | -$5.5B | -$7.6B | -$8.2B |
| Acquisitions (Net) | $4.6B | $41M | $0 | $77M | $69M |
| Investment Purchases | $144M | -$41M | $0 | $0 | $0 |
| Investment Sales | $1M | $553M | $2M | $0 | $0 |
| Other Investing | -$167M | $532M | $493M | $168M | $0 |
| Investing Cash Flow | $764M | -$3.3B | -$5.0B | -$7.4B | -$8.2B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$953M | $1.3B | $2.4B | $5.4B | -$2.0B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$184M | -$230M | -$230M | -$246M | -$753M |
| Other Financing | -$751M | -$1.1B | -$1.2B | -$1.7B | $0 |
| Financing Cash Flow | -$1.9B | -$5M | $899M | $3.5B | $1.9B |
| Net Change in Cash | $37M | -$51M | $250M | -$201M | -$276M |
| Cash End of Period | $70M | $20M | $270M | $68M | $498M |
| Free Cash Flow | -$2.6B | -$1.1B | -$1.1B | -$4.0B | -$1.7B |